Viewing Study NCT00184561


Ignite Creation Date: 2025-12-24 @ 1:09 PM
Ignite Modification Date: 2026-01-01 @ 4:09 AM
Study NCT ID: NCT00184561
Status: COMPLETED
Last Update Posted: 2017-01-06
First Post: 2005-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module